C07K 16/1203 Gram-negative bacteria
Introduced: January 2026
Full Title
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies > against material from bacteria > Gram-negative bacteria
Classification Context
- Section:
- CHEMISTRY; METALLURGY
- Class:
- ORGANIC CHEMISTRY
- Subclass:
- PEPTIDES
Filing statistics
IPC C07K 16/1203 belongs to the parent subclass C07K, which recorded 434,419 patent applications worldwide between 2013 and 2023. Annual filings grew from 29,263 in 2013 to 39,574 in 2023 (+35%), peaking at 47,586 applications in 2021. The most active applicants in class C07 are CHINESE ACADEMY OF SCIENCES (12,697 applications), ROCHE (11,347 applications) and SINOPEC (CHINA PETROCHEMICAL CORPORATION) (11,024 applications).
Source: EPO PATSTAT, worldwide filings
7 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C07K 16/121 Helicobacter (G); Campylobacter (G)
- C07K 16/1214 Pseudomonadaceae (F)
- C07K 16/1217 Neisseriaceae (F)
- C07K 16/1218 Acinetobacter (G)
- C07K 16/1228 Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C07K 16/1246 Rickettsiales (O)
- C07K 16/126 Legionella (G)
Top Applicants
Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT
- CHINESE ACADEMY OF SCIENCES 12,697
- ROCHE CH 11,347
- SINOPEC (CHINA PETROCHEMICAL CORPORATION) 11,024
- NOVARTIS CH 9,356
- BASF (BADISCHE ANILIN & SODA FABRIK) DE 8,531
- BRISTOL-MYERS SQUIBB COMPANY US 7,320
- LG CHEM KR 7,245
- REGENERON PHARMACEUTICALS US 6,816
- HARVARD UNIVERSITY US 6,190
- GENENTECH US 5,922